References
- Casavecchia G, Lestuzzi C, Gravina M, et al. Cardiac tumors. J Cardiovasc Echography. 2020;30(5):S45–S53.
- MacGowan SW, Sidhu P, Aherne T, et al. Atrial myxoma: national incidence, diagnosis and surgical management. Ir J Med Sci. 1993;162(6):223–226.
- Veinot JP, Burns BF, Commons AS, et al. Cardiac neoplasms at the Canadian reference centre for cancer pathology. Can J Cardiol. 1999;15(3):311–319.
- Lumpuy-Castillo J, Lorenzo-Almorós A, Pello-Lázaro AM, et al. Cardiovascular damage in COVID-19: therapeutic approaches targeting the renin-angiotensin-aldosterone system. Int J Mol Sci. 2020;21(18):6471.
- Wiedermann CJ, Reinisch N, Fischer-Colbrie R, et al. Proinflammatory cytokines in cardiac myxomas. J Intern Med. 1992;232(3):263–265.
- Goetze JP, Bruneau BG, Ramos HR, et al. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698–717.
- Ogawa T, Vatta M, Bruneau BG, et al. Characterization of natriuretic peptide production by adult heart atria. Am J Physiol. 1999;276(6):H1977–H1986.
- Bensimon M, Chang AI, de Bold ML, et al. Participation of G proteins in natriuretic peptide hormone secretion from heart atria. Endocrinology. 2004;145(11):5313–5321.
- McGrath MF, de Bold AJ. Transcriptional analysis of the mammalian heart with special reference to its endocrine function. BMC Genomics. 2009;10:254.
- Chang AI, McGrath MF, de Bold AJ. Phospholipase C signaling tonically represses basal atrial natriuretic factor secretion from the atria of the heart. Am J Physiol Heart Circ Physiol. 2013;304(10):H1328–H1336.